129 related articles for article (PubMed ID: 30876929)
1. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
Neven B; Diana JS; Castelle M; Magnani A; Rosain J; Touzot F; Moreira B; Fremond ML; Briand C; Bendavid M; Levy R; Morelle G; Vincent M; Magrin E; Bourget P; Chatenoud L; Picard C; Fischer A; Moshous D; Blanche S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1363-1373. PubMed ID: 30876929
[TBL] [Abstract][Full Text] [Related]
2. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Mata JR; Zahurak M; Rosen N; DeZern AE; Jones RJ; Ambinder AJ
Transplant Cell Ther; 2024 Jun; 30(6):588-596. PubMed ID: 38521411
[TBL] [Abstract][Full Text] [Related]
3. Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Dimitrova D; Gea-Banacloche J; Steinberg SM; Sadler JL; Hicks SN; Carroll E; Wilder JS; Parta M; Skeffington L; Hughes TE; Blau JE; Broadney MM; Rose JJ; Hsu AP; Fletcher R; Nunes NS; Yan XY; Telford WG; Kapoor V; Cohen JI; Freeman AF; Garabedian E; Holland SM; Lisco A; Malech HL; Notarangelo LD; Sereti I; Shah NN; Uzel G; Zerbe CS; Fowler DH; Gress RE; Kanakry CG; Kanakry JA
Biol Blood Marrow Transplant; 2020 Jan; 26(1):94-106. PubMed ID: 31493539
[TBL] [Abstract][Full Text] [Related]
4. Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease.
Chopra Y; Acevedo K; Muise A; Frost K; Schechter T; Krueger J; Ali M; Chiang KY; Kim VH; Grunebaum E; Wall D
Transplant Cell Ther; 2024 May; 30(5):546.e1-546.e7. PubMed ID: 38458476
[TBL] [Abstract][Full Text] [Related]
5. [Current state of graft-versus-host disease prophylaxis with PTCy for allogeneic hematopoietic stem cell transplantation].
Nakamae H
Rinsho Ketsueki; 2024; 65(5):391-400. PubMed ID: 38825519
[TBL] [Abstract][Full Text] [Related]
6. Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
Albert MH; Sirin M; Hoenig M; Hauck F; Schuetz C; Bhattacharyya R; Stepensky P; Jacoby E; Güngör T; Beier R; Schulz A
Bone Marrow Transplant; 2021 Sep; 56(9):2248-2258. PubMed ID: 33967276
[TBL] [Abstract][Full Text] [Related]
7. Haploidentical haematopoietic stem cell transplantation combined with post-transplant cyclophosphamide in neuronal ceroid lipofuscinosis: Experience in eight patients.
Song Z; Cui X; Zhang Z; Liu R; Shi X
Med Clin (Barc); 2024 Mar; 162(5):244-249. PubMed ID: 38044188
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
Mohty R; Al Kadhimi Z; Kharfan-Dabaja M
Hematology; 2024 Dec; 29(1):2326384. PubMed ID: 38597828
[TBL] [Abstract][Full Text] [Related]
9. Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience.
Akram A; Gilani M; Chaudhry QUN; Iftikhar R; Ghafoor T; Khan MA; Haider M; Nisar H
Cureus; 2024 May; 16(5):e59744. PubMed ID: 38841039
[TBL] [Abstract][Full Text] [Related]
10. Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study.
Azari M; Barkhordar M; Bahri T; Rad S; Kamranzadeh Fumani H; Mousavi SA; Tavakoli Shiraji S; Azari M; Shafaroudi P; Vaezi M
Front Oncol; 2024; 14():1339605. PubMed ID: 38454927
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.
Lum SH; Albert MH; Gilbert P; Sirait T; Algeri M; Muratori R; Fournier B; Laberko A; Karakukcu M; Unal E; Ayas MF; Yadav SP; Fisgin T; Elfeky R; Fernandes JF; Faraci M; Cole T; Schulz AS; Meisel R; Zecca M; Ifversen M; Biffi A; Diana JS; Vallée TC; Giardino S; Ersoy GZ; Moshous D; Gennery AR; Balashov D; Bonfim CMS; Locatelli F; Lankester AC; Neven B; Slatter MA
Blood; 2024 Apr; ():. PubMed ID: 38669631
[TBL] [Abstract][Full Text] [Related]
12. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
Esquirol A; Pascual MJ; Kwon M; Pérez A; Parody R; Ferra C; Garcia Cadenas I; Herruzo B; Dorado N; Hernani R; Sanchez-Ortega I; Torrent A; Sierra J; Martino R;
Bone Marrow Transplant; 2021 Oct; 56(10):2432-2444. PubMed ID: 34059802
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution in children after haploidentical haematopoietic stem cell transplantation.
Apasuthirat S; Apiwattanakul N; Anurathapan U; Thokanit NS; Paisooksantivatana K; Pasomsub E; Hongeng S; Pakakasama S
Int J Lab Hematol; 2024 Apr; ():. PubMed ID: 38646695
[TBL] [Abstract][Full Text] [Related]
14. The rationale behind grafting haploidentical hematopoietic stem cells.
Maziarz RT; Cook RJ
Hematology; 2024 Dec; 29(1):2347673. PubMed ID: 38712914
[TBL] [Abstract][Full Text] [Related]
15. Changing outcomes of stem cell transplantation in primary immunodeficiencies: Results from a tertiary-care charitable trust hospital in Mumbai.
Pandrowala A; Desai M; Madkaikar M; Kulkarni S; Shobhavat L; Mishra J; Jain S; Chandane P; Sehgal K; Chavan S; Karkera P; Bendre P; Thanky A; Rao S; Prabhu S; Bodhanwala M; Agarwal B; Hiwarkar P
J Allergy Clin Immunol Glob; 2023 Aug; 2(3):100105. PubMed ID: 37779531
[TBL] [Abstract][Full Text] [Related]
16. An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
Kassim AA; de la Fuente J; Nur E; Wilkerson K; Alahmari A; Seber A; Bonfim CMS; Simões BP; Alzahrani M; Eckrich MJ; Horn B; Hanna R; Dhedin N; Rangarajan HG; Gouveia RV; Almohareb F; Aljurf M; Essa M; Alahmari B; Gatwood KS; Connelly JA; Dovern E; Rodeghier M; DeBaun MR
Blood; 2024 Mar; ():. PubMed ID: 38493482
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.
Morris EC
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):649-660. PubMed ID: 33275750
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution and survival, following hematopoietic stem cell transplantation in Omani patients with inborn errors of immunity.
Al-Tamemi S; Al-Rawas A; Al-Khabori M; Al-Farsi K; Al-Huneini M; Abdalla A; Al-Kindi S; Dennison D
Clin Immunol; 2024 May; 264():110263. PubMed ID: 38795901
[TBL] [Abstract][Full Text] [Related]
19. Neurologic Status of Patients with Purine Nucleoside Phosphorylase Deficiency Before and After Hematopoetic Stem Cell Transplantation.
Karaaslan BG; Turan I; Aydemir S; Meric ZA; Atay D; Akcay A; Sari AA; Hershfield M; Cipe F; Aksoy BA; Ersoy GZ; Bozkurt C; Demirkol YK; Ozturk G; Aydogmus C; Kiykim A; Cokugras H
J Clin Immunol; 2023 Nov; 43(8):2062-2075. PubMed ID: 37726596
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after hematopoietic stem cell transplantation for children with I-cell disease.
Lund TC; Cathey SS; Miller WP; Eapen M; Andreansky M; Dvorak CC; Davis JH; Dalal JD; Devine SM; Eames GM; Ferguson WS; Giller RH; He W; Kurtzberg J; Krance R; Katsanis E; Lewis VA; Sahdev I; Orchard PJ
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1847-51. PubMed ID: 25016194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
